Address
Other Office
410 - 22nd Street East #830
Saskatoon SK S7K 5T6
Canada
Phone
Website
Industry
Recent investment activity
KANDO id: 3306
Absorbed entities
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| GrowthWorks Canadian Fund Ltd | Venture | |||
| GrowthWorks Commercialization Fund | Venture | |||
| GrowthWorks Atlantic Venture Fund | Venture | |||
| GrowthWorks Opportunity Fund | Venture |
Funding rounds
Investment preferences
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 17 of 17| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | |||
|
|
AppZero Corp | Application virtualization software company. | N/A | |||
|
|
Inimex Pharmaceuticals Inc | Series B | ||||
|
|
Myxer Inc | N/A | ||||
|
|
NowPublic (NowPublic.com) | Crowdsourcing news network empowering the ordinary citizen. | N/A | |||
|
|
NxtPhase T&D Corp (Carmanah Engineering Ltd) | N/A | ||||
|
|
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | Series D | |||
|
|
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | Series C | |||
|
|
Celator Pharmaceuticals | Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. | N/A | |||
|
D-Wave Systems Inc | Developer of quantum computing systems. | Series F Follow-on investment | |||
|
|
D-Wave Systems Inc | Developer of quantum computing systems. | Series C Follow-on investment | |||
|
|
D-Wave Systems Inc | Developer of quantum computing systems. | Series B Follow-on investment | |||
|
General Fusion Inc | General Fusion is developing fusion technology to generate affordable, safe and plentiful energy. | Venture Follow-on investment | |||
|
|
General Fusion Inc | General Fusion is developing fusion technology to generate affordable, safe and plentiful energy. | Series B Follow-on investment | |||
|
|
General Fusion Inc | General Fusion is developing fusion technology to generate affordable, safe and plentiful energy. | Series A Initial investment | |||
|
|
MSI Methylation Sciences Inc | N/A | ||||
|
|
xkoto Inc | Series B |